# Predicting Response to Standardized Pediatric Colitis Therapy

> **NCT01536535** · PHASE4 · COMPLETED · sponsor: **Connecticut Children's Medical Center** · enrollment: 431 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Mesalazine
- **DRUG:** IV Corticosteroid
- **DRUG:** Oral Corticosteroids
- **OTHER:** Additional Therapies
- **PROCEDURE:** Colectomy

## Key facts

- **NCT ID:** NCT01536535
- **Lead sponsor:** Connecticut Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-10
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 431 (ACTUAL)
- **Last updated:** 2019-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536535, "Predicting Response to Standardized Pediatric Colitis Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01536535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*